CELMED BIOSCIENCES
Celmed BioSciences Inc. is a private biopharmaceutical company in the field of oncology. Based in Montreal, Canada, Celmed BioSciences has multiple programs in various phases of clinical development. Celmed BioScience has developed a number of proprietary small molecule drugs from its technology platforms Theralux(tm) and ECTA. Investors in Celmed BioSciences include LSP, BioVeda Capital and GeneChem.
CELMED BIOSCIENCES
Social Links:
Industry:
Biotechnology
Founded:
2001-01-01
Address:
Saint Laurent, Quebec, Canada
Country:
Canada
Total Employee:
11+
Status:
Active
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2004-06-07 | NewBiotics | NewBiotics acquired by Celmed Biosciences | N/A |
More informations about "Celmed Biosciences"
Celmed BioSciences Company Profile 2024: Valuation, Investors ...
Celmed BioSciences General Information Description. Manufacturers of therapy-based medicines located in Saint Laurent, Canada. The company offers medicines for the treatments for …See details»
Kiadis and Celmed Merge to Create New Force in Oncology
Nov 30, 2006 The combination of Kiadis and Celmed BioSciences shall create a leading international biotechnology company with proven strengths in oncology, both in products and …See details»
Kiadis to merge with Canada's Celmed | Fierce Biotech
Nov 27, 2006 The Dutch biotech Kiadis and Montreal-based Celmed BioSciences say they will merge operations, both of which are focused on new oncology therapies. The merged …See details»
Kiadis BV And Celmed BioSciences Merge To Create New Force
Dec 12, 2006 Celmed BioSciences Inc. is a private biopharmaceutical company in the field of oncology. Based in Montreal, Canada, Celmed BioSciences has multiple programs in various …See details»
CelMed BioSciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore CelMed BioSciences, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 11 literature, Drug:NB-301, NB-201, Thymectacin.See details»
Celmed BioSciences - M&A Summary, Ownership, and Business …
Dec 11, 2006 Celmed BioSciences has acquired 1 company of its own. Celmed BioSciences has acquired in 1 US state. The Company’s most targeted sectors include healthcare services …See details»
Celmed Biosciences - Funding, Financials, Valuation & Investors
Organization. Celmed Biosciences . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Funding. ... Acquisitions. Edit Acquisitions Section. …See details»
Celmed BioSciences Company Profile | Management and
Find contact information for Celmed BioSciences. Learn about their Business Services market share, competitors, and Celmed BioSciences's email format.See details»
Celmed Biosciences - Crunchbase
Celmed BioSciences develops cell therapy-based treatments for hematological, immunological, and neurological disorders.See details»
Celmed BioSciences Inc - Company Profile and News
Company profile page for Celmed BioSciences Inc including stock price, company news, executives, board members, and contact informationSee details»
Celmed BioSciences - VentureRadar
Celmed BioSciences VentureRadar profile. Find out more about Celmed BioSciences including the VentureRadar Innovation and Growth scores, Similar Companies and more. ... Ardena …See details»
Kiadis, Celmed merge to create new force in oncology
Kiadis B V, a Dutch early product development company, and Celmed BioSciences Inc., a Canadian clinical product development company, have announced their plans to merge both …See details»
Celmed BioSciences Inc. - Company Information - 6sense.com
Find useful insights on Celmed BioSciences Inc.'s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Celmed …See details»
Kiadis Pharma acquires Celmed Biosciences - Crunchbase
Dec 11, 2006 Kiadis Pharma acquires Celmed Biosciences on 2006-12-11 for an undisclosed amount. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... Save . …See details»
Celmed BioSciences to focus activities in oncology; sells neurology ...
Montreal, QC – April 26, 2004 – Celmed BioSciences, a subsidiary of Theratechnologies that targets niche applications in oncology, has sold Celmed USA, a private company, and its …See details»
Similar companies to Celmed BioSciences | VentureRadar
Ardena. n/a. Founded 1994. Netherlands. Ardena is a fully integrated Contract Development & Manufacturing Organization (CDMO) with a core focus on bringing molecules to the clinics.See details»
Celmed Biosciences - Updates, News, Events, Signals & Triggers
Celmed BioSciences develops cell therapy-based treatments for hematological, immunological, and neurological disorders.See details»
Celmed Biosciences ... CELMED LTDA - business directory.
US Business Directory. State: United States. Businesses starting with CE. Page 441.See details»
NewBiotics - Crunchbase Company Profile & Funding
NewBiotics transforms drug resistances into therapeutic advantages. It focuses on the discovery and development of drug molecules that leverage the cycle of drug resistance in both cancer …See details»